ACM
AIGH Capital Management Portfolio holdings
AUM
$213M
This Quarter Return
+25.44%
1 Year Return
+95.37%
3 Year Return
+329.16%
5 Year Return
–
10 Year Return
–
AUM
$266M
AUM Growth
+$266M
(+24%)
Cap. Flow
+$17.9M
Cap. Flow
% of AUM
6.74%
Top 10 Holdings %
Top 10 Hldgs %
61.71%
Holding
45
New
6
Increased
14
Reduced
8
Closed
8
Top Buys
| 1 |
Marvell Technology
MRVL
|
$16.6M |
| 2 |
Verastem
VSTM
|
$13.8M |
| 3 |
Backblaze
BLZE
|
$10.8M |
| 4 |
Zevra Therapeutics
ZVRA
|
$6.58M |
| 5 |
Myomo
MYO
|
$3.88M |
Top Sells
| 1 |
Digital Turbine
APPS
|
$13.8M |
| 2 |
Corning
GLW
|
$7.13M |
| 3 |
Cellectar Biosciences
CLRB
|
$6.84M |
| 4 |
Delcath Systems
DCTH
|
$4.78M |
| 5 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$4.52M |
Sector Composition
| 1 | Healthcare | 64.48% |
| 2 | Technology | 22.66% |
| 3 | Industrials | 12.72% |
| 4 | Communication Services | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Personalis
PSNL
$434M
| $22M | 6.87% | 3,799,064 -200,000 | -5% | -$1.16M |
|
|
2
Myomo
MYO
$39.7M
| $21.8M | 6.81% | 3,381,567 +602,719 | +22% | +$3.88M |
|
3
Arq
ARQ
$330M
| $21.3M | 6.67% | 2,817,078 | – | – |
|
|
4
Delcath Systems
DCTH
$385M
| $16.7M | 5.22% | 1,385,389 -397,101 | -22% | -$4.78M |
|
|
5
Marvell Technology
MRVL
$54.2B
| $16.6M | 5.18% | +150,000 | New | +$16.6M |
|
6
scPharmaceuticals
SCPH
$295M
| $14.8M | 4.62% | 4,174,367 +50,000 | +1% | +$177K |
|
|
7
Verastem
VSTM
$569M
| $13.8M | 4.31% | +2,665,043 | New | +$13.8M |
|
8
Lightpath Technologies
LPTH
$230M
| $13.1M | 4.11% | 3,723,932 | – | – |
|
9
Tarsus Pharmaceuticals
TARS
$2.47B
| $12.4M | 3.89% | 224,713 +20,300 | +10% | +$1.12M |
|
10
Elutia
ELUT
$96.7M
| $11.5M | 3.6% | 3,074,675 +564,233 | +22% | +$2.11M |
|
|
11
Backblaze
BLZE
$471M
| $10.8M | 3.39% | +1,800,000 | New | +$10.8M |
|
12
Biodesix
BDSX
$62.6M
| $9.46M | 2.96% | 6,179,812 +500,000 | +9% | +$765K |
|
13
BK Technologies
BKTI
$264M
| $9.2M | 2.88% | 268,180 -14,592 | -5% | -$500K |
|
14
Xeris Biopharma Holdings
XERS
$1.26B
| $8.73M | 2.73% | 2,574,846 +389,192 | +18% | +$1.32M |
|
15
TELA Bio
TELA
$70.5M
| $8.04M | 2.51% | 2,662,785 +193,412 | +8% | +$584K |
|
16
Coya Therapeutics
COYA
$110M
| $6.88M | 2.15% | 1,201,152 +551,725 | +85% | +$3.16M |
|
|
17
Zevra Therapeutics
ZVRA
$509M
| $6.58M | 2.06% | +788,614 | New | +$6.58M |
|
|
ELVA
18
Electrovaya
ELVA
$243M
| $6.26M | 1.96% | 2,525,099 +77,473 | +3% | +$192K |
|
19
Ideal Power
IPWR
$44.5M
| $6.22M | 1.94% | 823,315 +123,315 | +18% | +$931K |
|
|
THTX
20
Theratechnologies
THTX
$149M
| $5.48M | 1.71% | 3,026,569 -698,635 | -19% | -$1.26M |
|
21
Intellicheck
IDN
$109M
| $4.53M | 1.42% | 1,617,696 -150,036 | -8% | -$420K |
|
|
22
Corning
GLW
$57.4B
| $3.56M | 1.11% | 75,000 -150,000 | -67% | -$7.13M |
|
23
PolyPid
PYPD
$53.3M
| $2.51M | 0.78% | 827,867 +148,199 | +22% | +$449K |
|
|
GRCE
24
Grace Therapeutics, Inc. Common Stock
GRCE
$41.9M
| $1.96M | 0.61% | 521,083 -120,000 | -19% | -$451K |
|
25
Franklin Wireless
FKWL
$52.3M
| $1.91M | 0.6% | 390,000 | – | – |
|